Corcept Therapeutics Inc reports results for the quarter ended in January 1 - Earnings Summary

Corcept Therapeutics Incorporated

31/10/2024 02:35

* Corcept Therapeutics Inc  CORT.OQ  reported quarterly
adjusted
earnings of 41 cents​​ per share for the quarter ended January
1, higher than the same quarter last year, when the company
reported EPS of 28 cents.  The mean expectation of five analysts
for the quarter was for earnings of 28 cents per share. Wall
Street expected results to range from 25 cents to 34 cents per
share.
    * Revenue rose 47.7% to $182.55 million from a year ago;
analysts
expected $171.97 million. 
    * Corcept Therapeutics Inc's reported EPS for the quarter
was 41
cents​.
    * The company reported quarterly net income of $47.21
million.
    * Corcept Therapeutics Inc shares had risen by 4.2% this
quarter and gained 48.4% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 2.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Corcept
Therapeutics Inc is $76.00 
This summary was machine generated from LSEG data October 31 at
02:35 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      0.28           0.41           Beat
 Jun. 30 2024      0.23           0.32           Beat
 Mar. 31 2024      0.22           0.25           Beat
 Dec. 31 2023      0.26           0.28           Beat